Capstan Medical

Santa Cruz, United States

Founded 2020

About Capstan Medical

Capstan Medical develops robotic-assisted catheter systems for structural heart valve replacement. Combines surgical robotics with catheter-based technology for less invasive mitral and tricuspid valve procedures. $31.4M Series B, $110M Series C (Dec 2024) from Eclipse, Intuitive Ventures. First-in-human trial 2025, pivotal trial 2026.

Key Products & Services

Robotic Mitral Valve System

Founded
2020
Employees
50-100
Funding
$150M

Quick Links

Company Details

Country
United States
City
Santa Cruz
State
California
Type
commercial